| Literature DB >> 6711691 |
Abstract
A chronic schizophrenic patient developed a fatal agranulocytosis 1 month after beginning to take carbamazepine for aggression. Routine hematological monitoring was not carried out. This case highlights the need for psychiatrists' increased awareness of the possible hematological complications of carbamazepine.Entities:
Mesh：
Substances：
Year: 1984 PMID： 6711691 DOI： 10.1176/ajp.141.5.687
Source DB: PubMed Journal: Am J Psychiatry ISSN： 0002-953X Impact factor: 18.112